635 related articles for article (PubMed ID: 20040863)
1. STAT3 and its activators in intestinal defense and mucosal homeostasis.
Hruz P; Dann SM; Eckmann L
Curr Opin Gastroenterol; 2010 Mar; 26(2):109-15. PubMed ID: 20040863
[TBL] [Abstract][Full Text] [Related]
2. The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium.
Satoh-Takayama N; Dumoutier L; Lesjean-Pottier S; Ribeiro VS; Mandelboim O; Renauld JC; Vosshenrich CA; Di Santo JP
J Immunol; 2009 Nov; 183(10):6579-87. PubMed ID: 19846871
[TBL] [Abstract][Full Text] [Related]
3. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense.
Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP
Immunity; 2008 Dec; 29(6):958-70. PubMed ID: 19084435
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.
Colonna M
Immunity; 2009 Jul; 31(1):15-23. PubMed ID: 19604490
[TBL] [Abstract][Full Text] [Related]
5. Regulation of intestinal homeostasis by innate and adaptive immunity.
Kayama H; Takeda K
Int Immunol; 2012 Nov; 24(11):673-80. PubMed ID: 22962437
[TBL] [Abstract][Full Text] [Related]
6. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
[TBL] [Abstract][Full Text] [Related]
7. Innate immune signalling at intestinal mucosal surfaces: a fine line between host protection and destruction.
Cario E
Curr Opin Gastroenterol; 2008 Nov; 24(6):725-32. PubMed ID: 19122523
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappa B in intestinal protection and destruction.
Spehlmann ME; Eckmann L
Curr Opin Gastroenterol; 2009 Mar; 25(2):92-9. PubMed ID: 19528876
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity in inflammatory bowel disease: state of the art.
Hisamatsu T; Ogata H; Hibi T
Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
[TBL] [Abstract][Full Text] [Related]
10. IL-12 and IL-23: master regulators of innate and adaptive immunity.
Langrish CL; McKenzie BS; Wilson NJ; de Waal Malefyt R; Kastelein RA; Cua DJ
Immunol Rev; 2004 Dec; 202():96-105. PubMed ID: 15546388
[TBL] [Abstract][Full Text] [Related]
11. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
12. Intestinal immune regulation as a potential diet-modifiable feature of gut inflammation and autoimmunity.
Sonier B; Patrick C; Ajjikuttira P; Scott FW
Int Rev Immunol; 2009; 28(6):414-45. PubMed ID: 19954357
[TBL] [Abstract][Full Text] [Related]
13. Effects of the oral administration of the exopolysaccharide produced by Lactobacillus kefiranofaciens on the gut mucosal immunity.
Vinderola G; Perdigón G; Duarte J; Farnworth E; Matar C
Cytokine; 2006 Dec; 36(5-6):254-60. PubMed ID: 17363262
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis.
Ciccia F; Accardo-Palumbo A; Alessandro R; Rizzo A; Principe S; Peralta S; Raiata F; Giardina A; De Leo G; Triolo G
Arthritis Rheum; 2012 Jun; 64(6):1869-78. PubMed ID: 22213179
[TBL] [Abstract][Full Text] [Related]
15. Role of the intestinal epithelium in orchestrating innate and adaptive mucosal immunity.
Maaser C; Kagnoff MF
Z Gastroenterol; 2002 Jul; 40(7):525-9. PubMed ID: 12122602
[TBL] [Abstract][Full Text] [Related]
16. Effects of IL-12 and IL-23 on antigen-presenting cells at the interface between innate and adaptive immunity.
Puccetti P; Belladonna ML; Grohmann U
Crit Rev Immunol; 2002; 22(5-6):373-90. PubMed ID: 12803317
[TBL] [Abstract][Full Text] [Related]
17. Contributions of mucosal immune cells to methotrexate-induced mucositis.
de Koning BA; van Dieren JM; Lindenbergh-Kortleve DJ; van der Sluis M; Matsumoto T; Yamaguchi K; Einerhand AW; Samsom JN; Pieters R; Nieuwenhuis EE
Int Immunol; 2006 Jun; 18(6):941-9. PubMed ID: 16636014
[TBL] [Abstract][Full Text] [Related]
18. STAT3 in immune responses and inflammatory bowel diseases.
Fu XY
Cell Res; 2006 Feb; 16(2):214-9. PubMed ID: 16474436
[TBL] [Abstract][Full Text] [Related]
19. Innate T cell responses in human gut.
Meresse B; Cerf-Bensussan N
Semin Immunol; 2009 Jun; 21(3):121-9. PubMed ID: 19231234
[TBL] [Abstract][Full Text] [Related]
20. The role of the novel Th17 cytokine IL-26 in intestinal inflammation.
Dambacher J; Beigel F; Zitzmann K; De Toni EN; Göke B; Diepolder HM; Auernhammer CJ; Brand S
Gut; 2009 Sep; 58(9):1207-17. PubMed ID: 18483078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
